Creative Planning’s Oncolytics Biotech ONCY Stock Holding History

Creative Planning’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.3K	Buy	14,545 +1,215	+9%	+$1.21K	﹤0.01%	4064
2025 Q4	$11.7K	Hold	13,330	–	–	﹤0.01%	3869
2025 Q3	$18.7K	Hold	13,330	–	–	﹤0.01%	3822
2025 Q2	$10.3K	Hold	13,330	–	–	﹤0.01%	3622
2025 Q1	$7.33K	Hold	13,330	–	–	﹤0.01%	3433
2024 Q4	$12.2K	Buy	13,330 +3,000	+29%	+$3.12K	﹤0.01%	3373
2024 Q3	$9K	Buy	+10,330	New	+$10.1K	﹤0.01%	3173
2021 Q2	–	Sell	-170,000	Closed	-$648K	–	2438
2021 Q1	$648K	Sell	170,000 -10,000	-6%	-$29.8K	﹤0.01%	1266
2020 Q4	$428K	Buy	180,000 +10,000	+6%	+$24K	﹤0.01%	1407
2020 Q3	$287K	Buy	170,000 +60,000	+55%	+$110K	﹤0.01%	1441
2020 Q2	$207K	Buy	110,000 +17,000	+18%	+$32K	﹤0.01%	1511
2020 Q1	$128K	Buy	+93,000	New	+$232K	﹤0.01%	1485

Other funds holding ONCY

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SFP

Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return

Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Creative Planning's ONCY Position: Q1 2026 in Review

Creative Planning increased its Oncolytics Biotech (ONCY) stake by 9.1% in Q1 2026, buying an estimated $1.21K and bringing the position to 14,545 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4064.

Creative Planning first reported a position in ONCY in Q1 2020 and has held it in 12 quarters since. The position peaked at $648K in Q1 2021. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

Creative Planning held 14,545 shares of Oncolytics Biotech worth $12.3K as of Q1 2026.
Creative Planning bought 1,215 Oncolytics Biotech shares in Q1 2026, an estimated $1.21K.
Oncolytics Biotech made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #4064 holding.
Creative Planning first reported a position in Oncolytics Biotech in Q1 2020 and has held it in 12 quarters since.
Creative Planning's Oncolytics Biotech position peaked at $648K in Q1 2021.
59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.